is it safe to switch from semaglutide to tirzepatide Switching between weight-loss medications Early Dose Escalation of Tirzepatide

The NNT for tirzepatide was 1.23 for achieving 10% weight loss, 1.55 for 15%, 2.07 for 20%, 3.16 for 25%, and 5.08 for 30%

Studies on arterial stiffness, mitochondrial health, and systemic inflammation suggest that cardiac aging begins long before any symptoms appear

As medication exposure increases, receptor activation increases

More research is needed into the effects of individual nutrients, specific foods, and dietary patterns in humans

GLP-1s are becoming increasingly popular as first-choice medications for obesityrelative to other drugs such as metformin and Qsymiabecause of changing patient preferences, differences in effectiveness, and the positive effects of GLP-1s on comorbidities, such as type 2 diabetes mellitus and hypertension

K., Chan, Y., Li, X